CME CME GROUP INC.
AI brief AI-written, not reviewed by a person
Latest period data show CME Group Inc. reporting 12 months to 2025-12-31 revenue of 6,520,600,000 USD and diluted EPS (year) of 11.16 USD per share, with 12 months to 2025-12-31 operating income of 4,229,500,000 USD and net income of 4,072,200,000 USD. For the most recent quarter, 3 months to 2026-09-30, revenue was 1,737,300,000 USD, operating income 1,141,400,000 USD, diluted EPS (quarter) 2.89 USD, and net income 1,036,900,000 USD. Total assets and liabilities at 2026-09-30 were 192,092,500,000 USD and 165,532,200,000 USD respectively, with stockholders’ equity at 26,560,300,000 USD.
- Revenue (year) for 12 months to 2025-12-31: 6,520,600,000 USD; (2024-12-31: 6,130,100,000 USD). [1]
- Diluted EPS (year): 12 months to 2025-12-31: 11.16 USD per share; 12 months to 2024-12-31: 9.67 USD per share. [1]
- Net income (year): 12 months to 2025-12-31: 4,072,200,000 USD; 12 months to 2024-12-31: 3,525,800,000 USD. [1]
- Operating income (year): 12 months to 2025-12-31: 4,229,500,000 USD; 12 months to 2024-12-31: 3,931,500,000 USD. [1]
- Operating cash flow (year): 12 months to 2025-12-31: 4,277,100,000 USD; 12 months to 2024-12-31: 3,690,500,000 USD. [1]
- Total assets: at 2026-09-30: 192,092,500,000 USD; at 2025-12-31: 198,424,200,000 USD. [1]
- Total liabilities: at 2026-09-30: 165,532,200,000 USD; at 2025-12-31: 169,696,000,000 USD. [1]
- Stockholders' equity: at 2026-09-30: 26,560,300,000 USD; at 2026-06-30: 26,520,400,000 USD; at 2025-12-31: 28,728,200,000 USD. [1]
- Diluted EPS (quarter): 3 months to 2026-09-30: 2.89 USD/shares. [1]
- Revenue (quarter): 3 months to 2026-09-30: 1,737,300,000 USD. [1]
- Operating income (quarter): 3 months to 2026-09-30: 1,141,400,000 USD. [1]
Written by OpenVibe.AI from the SEC numbers and filings on this page, not reviewed by a person. Informational only; not investment advice. Written from figures and filings up to (gpt-5-nano-2025-08-07).
Observations
| Metric | Value | Observed | Source | Retrieved | Freshness |
|---|---|---|---|---|---|
| Revenue (quarter) (3 months to 2026-09-30) | 1,737,300,000 USD | sec-companyfacts | current | ||
| Revenue (year) (12 months to 2025-12-31) | 6,520,600,000 USD | sec-companyfacts | current | ||
| Net income (quarter) (3 months to 2026-09-30) | 1,036,900,000 USD | sec-companyfacts | current | ||
| Net income (year) (12 months to 2025-12-31) | 4,072,200,000 USD | sec-companyfacts | current | ||
| Operating income (quarter) (3 months to 2026-09-30) | 1,141,400,000 USD | sec-companyfacts | current | ||
| Operating income (year) (12 months to 2025-12-31) | 4,229,500,000 USD | sec-companyfacts | current | ||
| Diluted EPS (quarter) (3 months to 2026-09-30) | 2.89 USD/shares | sec-companyfacts | current | ||
| Diluted EPS (year) (12 months to 2025-12-31) | 11.16 USD/shares | sec-companyfacts | current | ||
| Operating cash flow (quarter) (3 months to 2026-03-31) | 1,259,900,000 USD | sec-companyfacts | current | ||
| Operating cash flow (year) (12 months to 2025-12-31) | 4,277,100,000 USD | sec-companyfacts | current | ||
| Total assets (at 2026-09-30) | 192,092,500,000 USD | sec-companyfacts | current | ||
| Total liabilities (at 2026-09-30) | 165,532,200,000 USD | sec-companyfacts | current | ||
| Stockholders' equity (at 2026-09-30) | 26,560,300,000 USD | sec-companyfacts | current | ||
| Cash and equivalents (at 2026-09-30) | 2,198,500,000 USD | sec-companyfacts | current | ||
| Shares outstanding (at 2010-02-17) | 66,643,583 shares | sec-companyfacts | current |
Context
No reviewed context has been published for CME. The observations and documents below are shown as their sources stated them.
Documents
Source freshness
| Source | Freshness | Last successful fetch | Stale after | Sources reports |
|---|---|---|---|---|
| SEC EDGAR: company financial facts (XBRL) sec-companyfacts | current | 10080 min | ok | |
| SEC EDGAR: latest XBRL filings sec-xbrl-filings | current | 45 min | healthy |
Watch this instrument
Sign in to add CME to a private watchlist or to get an alert when a new document or observation arrives.
Machine-readable: CME.json (the same data with every timestamp and source).
Information only — not investment advice; no trading here. OpenVibe.Trade holds no money or assets, takes no orders and gives no personal recommendations.